Trial Profile
Efficacy and safety of thrombomodulin-alfa in treatment of disseminated intravascular coagulation in hospitalized patients with haematological malignancies.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2014
Price :
$35
*
At a glance
- Drugs Thrombomodulin alfa (Primary) ; Anticoagulants
- Indications Disseminated intravascular coagulation
- Focus Therapeutic Use
- 01 Jul 2014 New trial record